glob image
glob image

Cadila Launches Tarzed For Early-stage Breast Cancer

24th Jan, 2022 | News

Cadila Pharmaceuticals has launched trastuzumab under the brand name Tarzed. It is a humanized monoclonal antibody and is recommended for HER2-positive early-stage breast cancer and metastatic breast cancer.

Array
(
)